nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—atherosclerosis	0.767	1	CbGaD
Clenbuterol—ADRB3—Signaling by GPCR—CXCL8—atherosclerosis	2.78e-05	0.000119	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	2.77e-05	0.000119	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	2.77e-05	0.000119	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	2.73e-05	0.000117	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—BGN—atherosclerosis	2.72e-05	0.000117	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	2.71e-05	0.000116	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.7e-05	0.000116	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOA5—atherosclerosis	2.7e-05	0.000116	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MAPK3—atherosclerosis	2.67e-05	0.000115	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	2.65e-05	0.000114	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.62e-05	0.000112	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PLA2G1B—atherosclerosis	2.6e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	2.59e-05	0.000111	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TGFB1—atherosclerosis	2.59e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PDGFB—atherosclerosis	2.59e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	2.58e-05	0.000111	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—VEGFA—atherosclerosis	2.58e-05	0.000111	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.57e-05	0.00011	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—STAT3—atherosclerosis	2.56e-05	0.00011	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.54e-05	0.000109	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.54e-05	0.000109	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	2.54e-05	0.000109	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	2.52e-05	0.000108	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AGT—atherosclerosis	2.52e-05	0.000108	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ALOX5—atherosclerosis	2.51e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	2.5e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	2.5e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	2.49e-05	0.000107	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.49e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	2.48e-05	0.000106	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—LEP—atherosclerosis	2.47e-05	0.000106	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APOE—atherosclerosis	2.47e-05	0.000106	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	2.47e-05	0.000106	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CAV1—atherosclerosis	2.45e-05	0.000105	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	2.45e-05	0.000105	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	2.45e-05	0.000105	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APOA1—atherosclerosis	2.45e-05	0.000105	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MAPK3—atherosclerosis	2.44e-05	0.000105	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	2.44e-05	0.000105	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	2.44e-05	0.000105	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	2.44e-05	0.000105	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	2.44e-05	0.000105	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	2.42e-05	0.000104	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	2.39e-05	0.000102	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	2.39e-05	0.000102	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	2.39e-05	0.000102	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFB1—atherosclerosis	2.37e-05	0.000102	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ABCG1—atherosclerosis	2.37e-05	0.000101	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ESR1—atherosclerosis	2.36e-05	0.000101	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—F2—atherosclerosis	2.34e-05	0.0001	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—F2—atherosclerosis	2.33e-05	0.0001	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.32e-05	9.93e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—F2—atherosclerosis	2.29e-05	9.83e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NAMPT—atherosclerosis	2.25e-05	9.64e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	2.24e-05	9.62e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.24e-05	9.58e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—LIPC—atherosclerosis	2.23e-05	9.58e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CG—atherosclerosis	2.23e-05	9.57e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—LCAT—atherosclerosis	2.22e-05	9.54e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—FABP4—atherosclerosis	2.22e-05	9.54e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOC3—atherosclerosis	2.22e-05	9.52e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—LDLR—atherosclerosis	2.21e-05	9.46e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	2.19e-05	9.41e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOA4—atherosclerosis	2.18e-05	9.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CETP—atherosclerosis	2.16e-05	9.24e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP7A1—atherosclerosis	2.15e-05	9.2e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	2.14e-05	9.19e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—MAPK3—atherosclerosis	2.14e-05	9.17e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	2.13e-05	9.13e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—INS—atherosclerosis	2.11e-05	9.06e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	2.1e-05	8.99e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	2.09e-05	8.96e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	2.08e-05	8.93e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCL2—atherosclerosis	2.08e-05	8.92e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PLG—atherosclerosis	2.08e-05	8.9e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—SCARB1—atherosclerosis	2.06e-05	8.85e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.04e-05	8.77e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IGF1—atherosclerosis	2.04e-05	8.76e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	2.04e-05	8.76e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PLG—atherosclerosis	2.03e-05	8.7e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.01e-05	8.62e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.98e-05	8.5e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	1.97e-05	8.43e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—atherosclerosis	1.95e-05	8.38e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.95e-05	8.37e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—HMGCR—atherosclerosis	1.95e-05	8.36e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SERPINE1—atherosclerosis	1.94e-05	8.32e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	1.92e-05	8.24e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.9e-05	8.17e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	1.9e-05	8.14e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	1.89e-05	8.1e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.88e-05	8.06e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.88e-05	8.06e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.88e-05	8.06e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOA2—atherosclerosis	1.88e-05	8.06e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.86e-05	7.96e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	1.86e-05	7.96e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.85e-05	7.95e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NOS3—atherosclerosis	1.85e-05	7.95e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	1.85e-05	7.93e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOB—atherosclerosis	1.83e-05	7.87e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	1.82e-05	7.8e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	1.81e-05	7.74e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—AKT1—atherosclerosis	1.8e-05	7.73e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOB—atherosclerosis	1.79e-05	7.69e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—LPA—atherosclerosis	1.79e-05	7.69e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	1.79e-05	7.68e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—atherosclerosis	1.78e-05	7.65e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	1.78e-05	7.63e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	1.77e-05	7.57e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.76e-05	7.54e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	1.75e-05	7.51e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LPL—atherosclerosis	1.75e-05	7.51e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ABCA1—atherosclerosis	1.74e-05	7.45e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—BGN—atherosclerosis	1.74e-05	7.45e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.72e-05	7.39e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOA5—atherosclerosis	1.72e-05	7.37e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LPL—atherosclerosis	1.71e-05	7.35e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	1.7e-05	7.3e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.67e-05	7.16e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	1.67e-05	7.14e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	1.66e-05	7.11e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.65e-05	7.1e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	1.65e-05	7.08e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AKT1—atherosclerosis	1.65e-05	7.06e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CXCL8—atherosclerosis	1.64e-05	7.05e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.64e-05	7.02e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	1.62e-05	6.96e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.62e-05	6.95e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.62e-05	6.94e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	1.62e-05	6.93e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.6e-05	6.85e-05	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AKT1—atherosclerosis	1.59e-05	6.81e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—atherosclerosis	1.56e-05	6.7e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	1.53e-05	6.58e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	1.5e-05	6.44e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AGT—atherosclerosis	1.5e-05	6.42e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—HMOX1—atherosclerosis	1.49e-05	6.39e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—atherosclerosis	1.49e-05	6.38e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.48e-05	6.33e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NFKB1—atherosclerosis	1.47e-05	6.31e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOE—atherosclerosis	1.47e-05	6.3e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LEP—atherosclerosis	1.47e-05	6.3e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AGT—atherosclerosis	1.47e-05	6.29e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	1.45e-05	6.24e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	1.45e-05	6.22e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAPK8—atherosclerosis	1.45e-05	6.2e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AKT1—atherosclerosis	1.44e-05	6.18e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOE—atherosclerosis	1.44e-05	6.16e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LEP—atherosclerosis	1.44e-05	6.16e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.43e-05	6.15e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOB—atherosclerosis	1.43e-05	6.12e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.43e-05	6.11e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—LIPC—atherosclerosis	1.42e-05	6.11e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	1.42e-05	6.1e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	1.42e-05	6.09e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOC3—atherosclerosis	1.42e-05	6.07e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—LDLR—atherosclerosis	1.41e-05	6.03e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	1.4e-05	6.01e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTM1—atherosclerosis	1.39e-05	5.96e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—F2—atherosclerosis	1.38e-05	5.94e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CETP—atherosclerosis	1.37e-05	5.89e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	1.37e-05	5.88e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—LPL—atherosclerosis	1.36e-05	5.85e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—F2—atherosclerosis	1.35e-05	5.81e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—VEGFA—atherosclerosis	1.34e-05	5.72e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GPX1—atherosclerosis	1.33e-05	5.7e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	1.32e-05	5.68e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—STAT3—atherosclerosis	1.32e-05	5.67e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.32e-05	5.64e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	1.3e-05	5.56e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CD36—atherosclerosis	1.3e-05	5.55e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.28e-05	5.49e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	1.27e-05	5.44e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAPK3—atherosclerosis	1.26e-05	5.42e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—INS—atherosclerosis	1.25e-05	5.38e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—HMGCR—atherosclerosis	1.24e-05	5.33e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	1.24e-05	5.32e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	1.23e-05	5.29e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MTHFR—atherosclerosis	1.23e-05	5.26e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—INS—atherosclerosis	1.23e-05	5.26e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFB1—atherosclerosis	1.23e-05	5.25e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	1.21e-05	5.2e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	1.21e-05	5.18e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARA—atherosclerosis	1.2e-05	5.16e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	1.19e-05	5.09e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AGT—atherosclerosis	1.17e-05	5e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	1.15e-05	4.94e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOE—atherosclerosis	1.14e-05	4.9e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CAV1—atherosclerosis	1.13e-05	4.86e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOA1—atherosclerosis	1.13e-05	4.84e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	1.13e-05	4.83e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.12e-05	4.81e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ABCA1—atherosclerosis	1.11e-05	4.75e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	1.1e-05	4.72e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	1.08e-05	4.61e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CG—atherosclerosis	1.03e-05	4.42e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARG—atherosclerosis	9.95e-06	4.27e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—INS—atherosclerosis	9.76e-06	4.19e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	9.76e-06	4.18e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	9.54e-06	4.09e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—HMOX1—atherosclerosis	9.5e-06	4.08e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	9.42e-06	4.04e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	9.28e-06	3.98e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—atherosclerosis	9.23e-06	3.96e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	9.22e-06	3.95e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOB—atherosclerosis	9.1e-06	3.9e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	9.08e-06	3.89e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ALB—atherosclerosis	8.95e-06	3.84e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTM1—atherosclerosis	8.86e-06	3.8e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	8.82e-06	3.78e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	8.73e-06	3.74e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—LPL—atherosclerosis	8.69e-06	3.73e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	8.63e-06	3.7e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	8.58e-06	3.68e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NOS3—atherosclerosis	8.56e-06	3.67e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	8.56e-06	3.67e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	8.54e-06	3.66e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AKT1—atherosclerosis	8.52e-06	3.65e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GPX1—atherosclerosis	8.48e-06	3.64e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	8.4e-06	3.6e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	8.37e-06	3.59e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CD36—atherosclerosis	8.26e-06	3.54e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	7.92e-06	3.4e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	7.85e-06	3.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—atherosclerosis	7.83e-06	3.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MTHFR—atherosclerosis	7.83e-06	3.36e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	7.75e-06	3.32e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARA—atherosclerosis	7.68e-06	3.29e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	7.68e-06	3.29e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	7.5e-06	3.21e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AGT—atherosclerosis	7.44e-06	3.19e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	7.33e-06	3.14e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOE—atherosclerosis	7.29e-06	3.12e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	7.27e-06	3.12e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CAV1—atherosclerosis	7.22e-06	3.1e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOA1—atherosclerosis	7.2e-06	3.09e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	7.11e-06	3.05e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CG—atherosclerosis	6.58e-06	2.82e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARG—atherosclerosis	6.35e-06	2.72e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—INS—atherosclerosis	6.22e-06	2.67e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALB—atherosclerosis	5.71e-06	2.45e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—atherosclerosis	5.48e-06	2.35e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NOS3—atherosclerosis	5.46e-06	2.34e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—atherosclerosis	5.36e-06	2.3e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	5.06e-06	2.17e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—atherosclerosis	4.99e-06	2.14e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	4.95e-06	2.12e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AKT1—atherosclerosis	3.94e-06	1.69e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AKT1—atherosclerosis	2.51e-06	1.08e-05	CbGpPWpGaD
